These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 34415429)
1. The additional value of ONEST (Observers Needed to Evaluate Subjective Tests) in assessing reproducibility of oestrogen receptor, progesterone receptor, and Ki67 classification in breast cancer. Cserni B; Bori R; Csörgő E; Oláh-Németh O; Pancsa T; Sejben A; Sejben I; Vörös A; Zombori T; Nyári T; Cserni G Virchows Arch; 2021 Dec; 479(6):1101-1109. PubMed ID: 34415429 [TBL] [Abstract][Full Text] [Related]
2. ONEST (Observers Needed to Evaluate Subjective Tests) suggests four or more observers for a reliable assessment of the consistency of histological grading of invasive breast carcinoma: A reproducibility study with a retrospective view on previous studies. Cserni B; Bori R; Csörgő E; Oláh-Németh O; Pancsa T; Sejben A; Sejben I; Vörös A; Zombori T; Nyári T; Cserni G Pathol Res Pract; 2022 Jan; 229():153718. PubMed ID: 34920295 [TBL] [Abstract][Full Text] [Related]
3. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer. Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341 [TBL] [Abstract][Full Text] [Related]
4. Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens. Tendl-Schulz KA; Rössler F; Wimmer P; Heber UM; Mittlböck M; Kozakowski N; Pinker K; Bartsch R; Dubsky P; Fitzal F; Filipits M; Eckel FC; Langthaler EM; Steger G; Gnant M; Singer CF; Helbich TH; Bago-Horvath Z Virchows Arch; 2020 Oct; 477(4):545-555. PubMed ID: 32383007 [TBL] [Abstract][Full Text] [Related]
5. Estrogen and progesterone receptor assay in paraffin-embedded breast cancer--reproducibility of assessment. Chebil G; Bendahl PO; Fernö M; ; Acta Oncol; 2003; 42(1):43-7. PubMed ID: 12665330 [TBL] [Abstract][Full Text] [Related]
6. Interobserver agreement among pathologists for semiquantitative hormone receptor scoring in breast carcinoma. Cohen DA; Dabbs DJ; Cooper KL; Amin M; Jones TE; Jones MW; Chivukula M; Trucco GA; Bhargava R Am J Clin Pathol; 2012 Dec; 138(6):796-802. PubMed ID: 23161712 [TBL] [Abstract][Full Text] [Related]
7. Risk of recurrence estimates with IHC4+C are tolerant of variations in staining and scoring: an analytical validity study. Dodson A; Zabaglo L; Yeo B; Miller K; Smith I; Dowsett M J Clin Pathol; 2016 Feb; 69(2):128-35. PubMed ID: 26281860 [TBL] [Abstract][Full Text] [Related]
8. Quantitative immunohistochemistry using the CAS 200/486 image analysis system in invasive breast carcinoma: a reproducibility study. Makkink-Nombrado SV; Baak JP; Schuurmans L; Theeuwes JW; van der Aa T Anal Cell Pathol; 1995 Apr; 8(3):227-45. PubMed ID: 7547496 [TBL] [Abstract][Full Text] [Related]
9. Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information. Feeley LP; Mulligan AM; Pinnaduwage D; Bull SB; Andrulis IL Mod Pathol; 2014 Apr; 27(4):554-61. PubMed ID: 24051696 [TBL] [Abstract][Full Text] [Related]
10. Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility. Hida AI; Bando K; Sugita A; Maeda T; Ueda N; Matsukage S; Nakanishi M; Kito K; Miyazaki T; Ohtsuki Y; Oshiro Y; Inoue H; Kawaguchi H; Yamashita N; Aogi K; Moriya T J Clin Pathol; 2015 May; 68(5):356-61. PubMed ID: 25673730 [TBL] [Abstract][Full Text] [Related]
11. ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations. Cserni B; Kilmartin D; O'Loughlin M; Andreu X; Bagó-Horváth Z; Bianchi S; Chmielik E; Figueiredo P; Floris G; Foschini MP; Kovács A; Heikkilä P; Kulka J; Laenkholm AV; Liepniece-Karele I; Marchiò C; Provenzano E; Regitnig P; Reiner A; Ryška A; Sapino A; Stovgaard ES; Quinn C; Zolota V; Webber M; Glynn SA; Bori R; Csörgő E; Oláh-Németh O; Pancsa T; Sejben A; Sejben I; Vörös A; Zombori T; Nyári T; Callagy G; Cserni G Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831541 [TBL] [Abstract][Full Text] [Related]
12. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up. Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420 [TBL] [Abstract][Full Text] [Related]
13. Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines - a Swedish survey with central re-assessment. Ekholm M; Grabau D; Bendahl PO; Bergh J; Elmberger G; Olsson H; Russo L; Viale G; Fernö M Acta Oncol; 2015 Jul; 54(7):1040-8. PubMed ID: 25959664 [TBL] [Abstract][Full Text] [Related]
14. Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories. Regitnig P; Reiner A; Dinges HP; Höfler G; Müller-Holzner E; Lax SF; Obrist P; Rudas M; Quehenberger F Virchows Arch; 2002 Oct; 441(4):328-34. PubMed ID: 12404057 [TBL] [Abstract][Full Text] [Related]
15. Dual-energy CT quantitative parameters for evaluating Immunohistochemical biomarkers of invasive breast cancer. Wang X; Liu D; Zeng X; Jiang S; Li L; Yu T; Zhang J Cancer Imaging; 2021 Jan; 21(1):4. PubMed ID: 33413654 [TBL] [Abstract][Full Text] [Related]
16. Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status. Clarke RB; Laidlaw IJ; Jones LJ; Howell A; Anderson E Br J Cancer; 1993 Mar; 67(3):606-11. PubMed ID: 8439511 [TBL] [Abstract][Full Text] [Related]
17. An intra- and interobserver reproducibility analysis of the Ki-67 proliferation marker assessment on core biopsies of breast cancer patients and its potential clinical implications. Vörös A; Csörgő E; Nyári T; Cserni G Pathobiology; 2013; 80(3):111-8. PubMed ID: 23258384 [TBL] [Abstract][Full Text] [Related]
18. Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment. Ayad E; Soliman A; Anis SE; Salem AB; Hu P; Dong Y Diagn Pathol; 2018 Aug; 13(1):63. PubMed ID: 30153851 [TBL] [Abstract][Full Text] [Related]
19. Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early-stage luminal breast cancer. van Steenhoven JEC; Kuijer A; Kornegoor R; van Leeuwen G; van Gorp J; van Dalen T; van Diest PJ Histopathology; 2020 Oct; 77(4):579-587. PubMed ID: 32557844 [TBL] [Abstract][Full Text] [Related]
20. Stability of oestrogen and progesterone receptor antigenicity in formalin-fixed paraffin-embedded breast cancer tissue over time. Ehinger A; Bendahl PO; Rydén L; Fernö M; Alkner S APMIS; 2018 Sep; 126(9):746-754. PubMed ID: 30160021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]